Eterna Therapeutics announced promising preclinical results for its lead cell therapy, ERNA-101, aimed at treating ovarian cancer by activating the immune system. In a study conducted at MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback